uMed is a game-changing company that is revolutionizing the life science research industry. With a unique combination of real-world evidence (RWE) and patient-generated data, uMed is bridging the evidence gap and accelerating the progress of medical research.
At the core of uMed's success is their innovative ACCESS Research Platform, which is seamlessly integrated into a vast network of healthcare institutions worldwide. This platform enables researchers to easily access and engage with patients, tapping into a decentralized collection of electronic health records, clinical outcomes, patient-reported data, and biosamples.
Through this groundbreaking approach, uMed is able to provide researchers with a wealth of diverse and relevant data, significantly reducing the time and effort usually required to gather and analyze information. This not only speeds up the research process, but also enhances the quality and reliability of the results.